LOW INCIDENCE OF MYELODYSPLASIA (MDS) OR ACUTE-LEUKEMIA (AML) AFTER AUTOLOGOUS BLOOD OR MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION (TBI) FOR LYMPHOMA
M. Crump et al., LOW INCIDENCE OF MYELODYSPLASIA (MDS) OR ACUTE-LEUKEMIA (AML) AFTER AUTOLOGOUS BLOOD OR MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION (TBI) FOR LYMPHOMA, European journal of cancer, 33, 1997, pp. 406-406